Most telehealth companies do not make the medication they prescribe.
A separate pharmacy compounds, packages, and ships it. That pharmacy has its own licenses, inspection history, accreditation, recalls, and federal record.
Patients rarely get the name.
Vial reviewed 883 provider websites that could be evaluated. Only 54 identified at least one fulfillment pharmacy.
That is 6.1%.
The other 829 sites, 93.9%, gave patients no way to verify who would prepare and ship their medication.
The prescribing brand is only the front door
A clinic may handle the intake, collect payment, and write the prescription. The medication often comes from somewhere else.
That distinction matters for commonly prescribed products such as:
- Compounded semaglutide
- Compounded tirzepatide
- Testosterone
- Estrogen and progesterone
- Peptide formulations
- Other sterile injectables
Two providers can sell the same protocol at the same price while using pharmacies with very different regulatory histories.
One may work with an accredited compounder. Another may use a pharmacy with warning letters, inspection findings, or recalls. A third may change fulfillment partners without making that change obvious to patients.
The websites can look identical.
The supply chains may not be.
Most review sites cannot answer the basic sourcing question
Telehealth rankings usually focus on price, convenience, and customer reviews.
They publish star ratings. They compare membership fees. They name a “best” provider, often through an affiliate link.
Few identify the pharmacy behind the prescription.
That leaves out the party responsible for preparing the product a patient injects, swallows, or applies.
A review that cannot trace the medication to its source has evaluated the storefront, not the full treatment.
The numbers
Vial began with 957 providers in its index.
We removed businesses that could not be fairly included in the analysis:
| Segment | Count |
|---|---|
| Providers in the Vial index | 957 |
| Excluded before crawling | 59 |
| Sites researched | 898 |
| Excluded as blocked or unreadable | 15 |
| Eligible provider sites | 883 |
| Named at least one fulfillment pharmacy | 54 (6.1%) |
| Silent on pharmacy fulfillment | 829 (93.9%) |
| Pharmacy mentions extracted | 160 |
| Mentions matching pharmacies already indexed by Vial | 40 |
The initial exclusions included:
- 51 businesses that were pharmacies themselves
- 3 providers that dispensed only through pharmacies they owned
- 5 providers without functioning websites
Generic statements did not count as disclosure.
Phrases such as “licensed U.S. pharmacies,” “trusted pharmacy partners,” or “our network of compounders” identify no specific business and give patients nothing to verify.
94% disclose no fulfillment pharmacy
Some providers use several pharmacies
The 54 disclosing sites produced 160 pharmacy mentions.
Some providers named two or three fulfillment partners. That may reflect state licensing limits, medication availability, capacity, or changes in sourcing.
It also creates another problem.
A patient may know which pharmacies a provider uses without knowing which one will fill the actual prescription. The source can depend on location, product, or timing.
Partial disclosure still beats silence. It does not always create full traceability.
We tested the method before running the study
Vial first tested the extraction process against four providers whose pharmacy relationships had already been verified manually.
The first version missed known disclosures.
We revised the logic, ran the validation again, and expanded the research only after the test worked.
Each site was then checked across as many as 19 common disclosure locations, including:
- Terms of service
- Privacy policies
- Shipping pages
- Treatment pages
- Frequently asked questions
- Consent documents
- Footer links
- Legal disclosures
Pharmacy names often appear far from the main sales pages.
The 6.1% figure is probably a floor
Some disclosures may live on separate domains with no clear link from the provider’s website.
We found one such case during validation. A manual web search surfaced the pharmacy relationship, but the provider site offered no discoverable path to it.
That means the true disclosure rate may sit slightly above 6.1%.
Perhaps it is 7% or 8%.
It is not close to broad transparency.
Silence does not prove misconduct
A provider’s failure to name its pharmacy does not establish illegal conduct, poor medication quality, or unsafe care.
Federal law does not generally require telehealth clinics to publish fulfillment partners on their public websites. Many silent providers may use properly licensed pharmacies with clean records.
The problem is simpler.
Patients cannot investigate a pharmacy they cannot identify.
Public records may include:
- FDA warning letters
- Form 483 inspection observations
- Product recalls
- State pharmacy discipline
- OIG exclusions
- DEA registration actions
- Accreditation status
Those records only become useful once the pharmacy has a name.
Pharmacy disclosure makes the public record usable
When a provider names a fulfillment pharmacy, Vial links that relationship to the pharmacy’s profile and available federal records.
Patients can then evaluate both sides of the transaction:
- The clinic prescribing the treatment
- The pharmacy preparing and shipping it
That should be standard consumer information.
For now, it remains the exception.
Data: Vial provider index, July 8, 2026 outputs. See also the companion Compounder Enforcement Study. Corrections: hello@getvial.com. Index methodology: Vial methodology.